Maynard Um
-
-
-
-
-
-
-
Helus Pharma names former Intra-Cellular president as new CEO
-
-
-
-
-
-
-
Helus Pharma closes $50M share offering at $4.85 per share
-
-
-
-
-
-
-
Jefferies Reiterates Buy Rating on Helus Pharma (HELP) following Phase 2 data; "add'l data is needed for the Street to have greater confidence"
-
467,369 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


